Jakub Słupski

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Oxide Nanoparticles

Major Depressive Disorder

Top Venues

Psychiatry and clinical psychopharmacology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Agnieszka Mechlińska, Mariusz S Wiglusz, Jakub Słupski, Adam Wlodarczyk, Wiesław Jerzy Cubała
Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals. Brain sciences 13 (9) (2023)
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Maria Gałuszko-Węgielnik
Copper and Impulsivity in Ketamine Treatment for Treatment-Resistant Mood Disorders. Psychiatry and clinical psychopharmacology 31 (3) (2021)
Natalia Górska, Wiesław Jerzy Cubała, Jakub Słupski, Mariusz Stanisław Wiglusz, Maria Gałuszko-Węgielnik, Mateusz Kawka, Agata Grzegorzewska
Magnesium in Ketamine Administration in Treatment-Resistant Depression. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Maria Gałuszko-Węgielnik
Copper and Impulsivity in Ketamine Treatment for Treatment-Resistant Mood Disorders. Psychiatry and clinical psychopharmacology 31 (3) (2021)
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Anita Słupska, Maria Gałuszko-Węgielnik
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression. Brain sciences 10 (12) (2020)